Both medications are typically administered as once-weekly injections, providing convenience and ease for our patients
In fact, one study showed that people who discontinued Wegovy (another GLP-1) regained 65% of the weight they had lost within less than a year
Diabetologia 65(Suppl 1):S288S288 Samms RJ, Zhang G, He W et al (2022) Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue
Next, find your BMI on the chart below to see if youre within the indicated range for GLP-1 treatment: *The above chart is not meant for medical diagnosis purposes
This is the question I get most, so let me be very clear
If youre ready to find out whether you qualify and which medication fits your situation, take the intake assessment to get started with a provider